Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial

AIMS: Digoxin is recommended for long-term rate control in paroxysmal, persistent, and permanent atrial fibrillation (AF). While some analyses suggest an association of digoxin with a higher mortality in AF, the intrinsic nature of this association has not been examined in propensity-matched cohorts...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gheorghiade, Mihai, Fonarow, Gregg C., van Veldhuisen, Dirk J., Cleland, John G.F., Butler, Javed, Epstein, Andrew E., Patel, Kanan, Aban, Inmaculada B., Aronow, Wilbert S., Anker, Stefan D., Ahmed, Ali
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2013
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659306/
https://ncbi.nlm.nih.gov/pubmed/23592708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/eht120
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller